Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.

Proceedings of the National Academy of Sciences of the United States of America - 11 Mar 2008

Bakker Arnold H, Hoppes Rieuwert, Linnemann Carsten, Toebes Mireille, Rodenko Boris, Berkers Celia R, Hadrup Sine Reker, van Esch Wim J E, Heemskerk Mirjam H M, Ovaa Huib, Schumacher Ton N M

Abstract excerpt

Major histocompatibility complex (MHC) class I multimer technology has become an indispensable immunological assay system to dissect antigen-specific cytotoxic CD8(+) T cell responses by flow cytometry. However, the development of high-throughput assay systems, in which T cell responses against a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HLA-A Antigens
Share to HLA-A1 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-A11 Antigen

Share to HLA-A3 Antigen

Share to HLA-B7 Antigen

Share to Inhibitory Concentration 50

Share to Protein Engineering

Share to Protein Structure, Quaternary

Source

Open in PubMed Open full text

Identifiers

PMID: 18308940
DOI: 10.1073/pnas.0709717105
PMCID: PMC2268811

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-18308940-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Conditional MHC class I ligands and peptide exchange technology for the human MHC gene products HLA-A1, -A3, -A11, and -B7.PMID 18308940Read ↗

Temperature-based MHC class-I multimer peptide exchange for human HLA-A, B and CSemantic proximity Read ↗

The isolated major histocompatibility complex class I alpha3 domain binds beta2m and CD8alphaalpha dimers.Semantic proximity Read ↗

Antigen‐specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapySemantic proximity Read ↗

Production and crystallization of MHC class I B allele single peptide complexes.Semantic proximity Read ↗

HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients.Semantic proximity Read ↗

Baculoviral expressed HLA class I heavy chains used to screen a synthetic peptide library for allele-specific peptide binding motifs.Semantic proximity Read ↗

Construction of MHC class I-peptide tetrameric complexes for analysis of T-cell-mediated immune responses.Semantic proximity Read ↗

High-throughput engineering and analysis of peptide binding to class II MHC.Semantic proximity Read ↗

Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides.Semantic proximity Read ↗

Universal open MHC-I molecules for rapid peptide loading and enhanced complex stability across HLA allotypesSemantic proximity Read ↗

Affinity, specificity and T-cell-receptor diversity of melanoma-specific CTL generated in vitro against a single tyrosinase epitope.Semantic proximity Read ↗

Design, engineering and production of functional single-chain T cell receptor ligandsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.